Shiga toxin and the closely related Shiga-like toxins produced by Escherichia coli represent a group of very similar cytotoxins that may play an important role in diarrheal disease and hemolytic uremic syndrome. These toxins have the same biologic activities and according to recent studies also share the same binding receptor, globotriosyl ceramide (Gb3). They are currently detected, on the basis of their ability to damage several cell lines, by using expensive and tedious assays that require facilities for and experience with tissue cultures and are therefore most suitable for research laboratories. We have developed a rapid method to detect Shiga toxin and Shiga-like toxin I based on specific binding to their Gb3 natural receptor, which was coated onto microdilution plates. Bound toxin was then detected by enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies. The sensitivity of the Gb3 ELISA was 0.2 ng (2 ng/ml) of purified toxin. The assay was positive with sonic extracts of Shigella dysenteriae serotype 1 strain 60R (a Shiga toxin producer), E. coli serotype 026:Hll1 strain 1H30, and E. coli serotype 0157:H7 (both Shiga-like toxin I producers). The assay was very specific in that no cross-reactivity was noted with purified cholera toxin, E. coli heat-labile and heat-stable enterotoxins, and Clostridium difficile cytotoxin, or sonic extracts of other cytotoxin-producing organisms, such as other shigellae, pathogenic and nonpathogenic E. coli, Salmonella spp., Campylobacter spp., and Aeromonas spp. These results were in complete agreement with a [3H]thymidine-labeled HeLa cell cytotoxicity assay and with detection of the structural genes by DNA hybridization studies with a Shiga-like toxin I probe. Quantitative analysis showed a high correlation between Gb3 ELISA and HeLa cell assay when fractions obtained at various stages of toxin purification were examined by both methods (r = 0.99, P < 0.01). This rapid Gb3 ELISA is sensitive and specific and may be diagnostically useful in cytotoxin-related infections.
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Cytotoxin production by enteric organisms has been increasingly investigated in recent years. Information regarding the role of cytotoxins in the intestinal manifestations of Shigella spp. (26) , Escherichia coli (6) , and Clostridium difficile (3) is gradually accumulating. Hemorrhagic colitis syndrome has been recently defined and related to high-level cytotoxin-producing E. coli, such as serotypes 0157:H7 and 026:H11, which have been called enterohemorrhagic E. coli (19, 24, 27, 29) . In addition, cytotoxin production probably plays a major pathogenic role in the development of hemolytic uremic syndrome (HUS) (5, 12) . For example, E. coli 0157:H7 has been observed in one-half of the patients with HUS during a prospective study in the northwestern United States (20) , and the syndrome developed in 22% of patients involved in an outbreak of hemorrhagic colitis related to this organism (4) . Evidence of infection with cytotoxin-producing E. coli has been demonstrated in 75% (12) to 88% (5) of patients with idiopathic HUS. It is currently thought that the cytotoxins damage vascular endothelial cells, thereby initiating the abnormalities of HUS (5) .
The cytotoxins are defined by their ability to damage mammalian cells. Among the most important cytotoxins are Shiga toxin, produced by Shigella strains (mainly Shigella dysenteriae serotype 1) (2, 21) , and the closely related Shiga-like toxins (SLTs), produced by E. coli (23) . The latter are also referred to as verotoxins by those who assay cytotoxic activity in Vero cells (15) . At least two immunologically distinct toxins, SLT-I and SLT-II, have been defined (19, 25, 29) . SLT-I is neutralized by antibodies raised * Corresponding author. against Shiga toxin, to which it is virtually identical; there is only a three-nucleotide difference, resulting in a singleamino-acid difference, between the two toxins (11). Although immunologically distinct, SLT-II is very similar to Shiga toxin and SLT-I with regard to structure and biologic activities. These toxins act by inhibiting protein synthesis by catalytic inactivation of the 60S ribosomal subunits. Recent studies have shown that these toxins also share the same glycosphingolipid receptor, globotriosyl ceramide (Gb3) (9, 10, 16, 17, 31) . Other less-defined variants of SLTs also exist (23) .
The cytotoxins are currently determined by their damage to several cell lines, which is usually evidenced by morphologic changes. These assays are expensive and tedious. They require facilities for and experience with tissue cultures and are therefore not suitable for routine usage and less-wellequipped laboratories. In light of recent data indicating that the well-defined cytotoxins share the same binding receptor, we have developed a rapid-detection method for Shiga toxin and SLT-I based on their binding to Gb3, the natural receptor, with detection of bound toxin by enzyme-linked immunosorbent assay (Gb3 ELISA). Results were compared with cytotoxicity determined by a quantitative radiolabeled HeLa cell assay that we have described previously (2, 6, 26) and with the structural genes for toxin production detected by DNA hybridization assay (21, 22) .
(This paper was presented in part at the annual meetings of the Southern Society for Pediatric Research, New Orleans, Preparation of purified Shiga toxin. Shiga toxin was purified from a sonic extract of S. dysenteriae serotype 1 strain 60R by Affi-Gel Blue column, chromatofocusing, and hydroxylapatite column, as we have described elsewhere (26) . The final cytotoxic fraction was electrophoresed on sodium dodecyl sulfate-polyacrylamide gel (15%) under denaturing conditions (,-mercaptoethanol), and purity was confirmed with silver staining. The purified toxin had a specific activity of 107 3 50% cytotoxic doses (CD50) per mg of protein.
Preparation of anti-Shiga toxin serum. Rabbit anti-Shiga toxin serum, which also neutralized SLT-I, was obtained by repeated injections of formaldehyde-treated purified Shiga toxin (100 Ftg per dose) in complete Freund adjuvant as previously described (2) .
Gb3 ELISA. The detailed procedure of the Gb3 ELISA is described in Table 1 (2) . Neutralization studies were performed by preincubation of the toxin (4 h, 37°C) with rabbit anti-Shiga-toxin serum or rabbit nonimmune serum (2, 26) followed by determination of cytotoxicity with radiolabeled HeLa cells as described above.
DNA hybridization studies. The DNA probe for SLT-I was provided by J. W. Newland and R. J. Neill (Walter Reed Army Institute of Research, Washington, D.C.). The probe is a 1,142-base-pair BamHI fragment of the recombinant plasmid pJN37-19, cloned from E. coli bacteriophage 933J (22) . As Shiga toxin and SLT-I differ in only three nucleotides, the SLT-I probe also hybridizes with Shiga toxinproducing organisms. The probe was extracted from lowtemperature-gelling agarose and labeled by nick translation Purified toxin (ng/ml) FIG Statistical analysis. Neutralization studies were done in triplicate, and the Student t test was used to examine the statistical significance of the differences between toxin fractions preincubated with anti-Shiga toxin serum or with nonimmune serum.
RESULTS
Gb3 ELISA. We found that the Gb3 concentration for coating the plates which gave highest sensitivity and reproducibility was 10 to 30 ,ug/ml; 10 ,ug/ml was then used in all further assays and for evaluation of the method. Coating was achieved after 4 (Fig. 1) . The assay was capable of detecting as little as 0.2 ng of toxin (100 ,ul of 2-ng/ml purified toxin). The assay was positive with sonic extracts of S. dysenteriae serotype 1 strain 60R (Shiga toxin), E. coli 026:H11 strain H30 (SLT-I), and E. coli 0157:H7 (SLT-I) until a dilution of at least 1:256 (initial concentration, 1 mg of bacterial protein per ml) was achieved. In addition, culture supernatants were also examined and gave positive results, although optic densities suggest that the amount of toxin detected was about fivefold lower than that in sonic extracts.
VOL. 27, 1989 on October 28, 2017 by guest http://jcm.asm.org/ Downloaded from Readings of Gb3 ELISA (A49.) were expressed as micrograms of purified Shiga toxin, obtained from the titration curve of purified toxin. The fractions examined were (dots from left to right) crude sonicate of S. dysenteriae 1 strain 60R, cytotoxic fraction eluted from Affi-Gel Blue column, cytotoxic fraction eluted by chromatofocusing, and purified Shiga toxin. A high correlation was found between specific activity and Gb3 ELISA readings (r = 0.99, P < 0.01).
during purification of the toxin resulted in simultaneous increased readings in the Gb3 ELISA and higher amounts of toxin detected (Fig. 2) . Regression analysis indicated a high correlation between the two methods (r = 0.99, P < 0.01). The effect of heat treatment (100°C, 30 min) on purified Shiga toxin and sonic extracts of E. coli 026:H11 strain H30 (SLT-I) was examined. Heating caused inactivation of most cytotoxic activity in the HeLa cell assay (Fig. 3B) and at the same time reduced the absorbance in the Gb3 ELISA method to near zero (Fig. 3A) . In addition, when various bacterial sonic extracts were examined, all extracts positive for Shiga toxin or SLT-I in the cytotoxicity assay (neutralized by rabbit antiserum to Shiga toxin) or hybridized with DNA probe for SLT-I were also positive in the Gb3 ELISA. Bacterial sonic extracts negative in the cytotoxicity assay (no neutralization with an anti-Shiga toxin serum) and in DNA hybridization assays were always negative in the Gb3 ELISA ( Table 2) . DISCUSSION Shiga toxin and SLTs are currently diagnosed by biologic assays. Three biologic activities have been ascribed to these cytotoxins: lethality in mice, fluid accumulation in ligated rabbit ileal loops, and toxic activity in several cell lines (8) . Of these, the assays most frequently used to detect specific activity are based on cytotoxicity in HeLa or Vero cells. These assays are complicated, cumbersome, and time-consuming, and they require facilities for and experience with tissue cultures. They are usually based on cytotoxin-related morphologic changes of the cells or on radiolabeled assays. Identification of the specific cytotoxin also requires neutralization studies with the appropriate antiserum. In addition, the sensitivities of various cell lines to cytotoxic effects vary significantly (23) . ELISA methods that use monoclonal antibodies to detect these cytotoxins have been described elsewhere (7, 14) .
Recent data have showed that Shiga toxin, SLT-I, and SLT-II share the same binding receptor, Gb3 (10, 16, 31) . Because these well-defined toxins are emerging as the most important and clinically relevant cytotoxins produced by members of the family Enterobacteriaceae, we have developed a rapid diagnostic assay based on specific binding to this receptor; bound Shiga toxin or SLT-I was then detected immunologically. Gb3 was obtained from the manufacturer in chloroform-methanol (2:1) solution. The Gb3 was difficult to get into aqueous solution. Organic solvents were therefore used, and a special method for coating onto microdilution plates was necessary. A similar principle has been used to detect heat-labile enterotoxins by using their specific binding to the GM1 receptor (30) . However, since GM1 is water soluble, it has been diluted in PBS, and a standard procedure has been used for coating.
The present study shows that the Gb3 ELISA is sensitive and specific, detecting nanogram quantities of purified Shiga toxin. Sonic extracts of SLT-I-producing organisms (E. coli 026:H11 and E. coli 0157:H7) were also positive in this assay. Production of SLT-I by these organisms was verified both by neutralization studies with specific antiserum and by DNA hybridization. The specificity of the assay was high, in that no cross-reactivity was found with SLT-II or cytotoxins produced by a variety of other organisms, including other Shigella and E. coli strains and Salmonella, Campylobacter, and Aeromonas strains. Lack of SLT-I production was demonstrated in all of these strains by neutralization studies with specific antiserum in a HeLa cell assay, and in most of them, SLT-I production was also demonstrated by DNA hybridization studies. Quantitative correlation with the radiolabeled HeLa cell assay was demonstrated by examination of fractions at the various stages of toxin purification by both methods. Because Gb3 is also the binding receptor of SLT-II (31), the latter toxin might also be detected by the same method by appropriate monoclonal antibodies to SLT-II. It would be very helpful if plates precoated with Gb3 could be used to detect the main cytotoxins, with specific identification of bound toxins by use of distinct antibodies.
The present Gb3 ELISA has obvious advantages over the HeLa or Vero cell assays: (i) it is inexpensive, simple, and rapid, can be performed in one working day, and can be used by relatively inexperienced personnel; (ii) there is no need for experience with or facilities for tissue cultures; (iii) Gb3, the monoclonal antibodies (American Type Culture Collection, cell line 13C4), and the second antibodies (rabbit anti-mouse immunoglobulin G) are commercially available; and (iv) objective results are obtained (optical density at 490 nm) rather than subjective interpretation of morphologic changes in cell lines.
The Gb3 ELISA seems comparable to the ELISA (7, 14) . The methods described used anti-Shiga toxin monoclonal antibodies (7) or antibodies purified by immunoaffinity column chromatography (14) and then detection by enzyme immunoassay. The sensitivities of the assays were 0.06 ng/ml (7) and about 10 ng/ml (14) , and the assays were specific when tested with other toxins. However, the entire Gb3 ELISA can be performed in one working day, the assay is based on commercially available materials, and it has the potential advantage of detecting additional cytotoxins that bind to Gb3 as their natural receptor.
Any rapid and simple method to detect this group of cytotoxins is of prime importance, as it may be also used by less-well-equipped laboratories, for example, in developing countries. This may significantly simplify epidemiologic studies of cytotoxin-related infections and increase our understanding of the role of these toxins in diarrheal disease and HUS.
